ORAGENICS INC (OGEN) Stock Income Statement
NYSEARCA:OGEN - NYSE Arca - US6840235005 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 37.70K | 130.00K | 90.00K | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 10.56M | 20.94M | 14.55M | 15.86M | 26.64M | |||
| Research and Development | 4.11M | 15.49M | 10.07M | 10.59M | 22.11M | |||
| Selling, General, and Administrative Expenses | 6.44M | 5.45M | 4.47M | 5.27M | 4.53M | |||
| Operating Income | -10.56M | -20.90M | -14.42M | -15.77M | -26.64M | |||
| Interest Income/Expense | -9.10K | 179.80K | 120.00K | 60.00K | 80.00K | |||
| Other Income/Expense | N/A | 69.40K | 10.00K | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 130.00K | |||
| Income Before Taxes | -10.57M | -20.66M | -14.29M | -15.71M | -26.43M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Net Income | -10.57M | -20.66M | -14.29M | -15.71M | -26.43M | |||
| EBITDA | N/A | -20.88M | -14.38M | -15.73M | -26.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.60 | -9.18 | -7.11 | -8.35 | -28.11 | |||
| Non GAAP EPS | N/A | N/A | -6.75 | -5.45 | -0.48 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -54789.66% | -10992.31% | -17455.56% | N/A | |||
| Operating Profit Margin | N/A | -55450.66% | -11092.31% | -17522.22% | N/A | |||
All data in USD